Pre-hospital Advanced Therapies for Control of Hemorrhage - Pelvis
- Conditions
- HemorrhagePelvic Fracture
- Interventions
- Device: Pelvic Binder
- Registration Number
- NCT02855060
- Lead Sponsor
- Wake Forest University Health Sciences
- Brief Summary
The purpose of this study is to determine whether the use of pelvic binders in the ambulance setting improves outcomes including mortality in patients with pelvic fractures.
- Detailed Description
The goal of this prospective, randomized clinical trial is to determine whether prehospital use of a commercial pelvic binder will improve morbidity and mortality in patients with pelvic fractures. We hypothesize that prehospital placement of pelvic binders will reduce hemorrhage and need for resuscitation and will improve overall mortality in patients with pelvic fractures. In addition, we hypothesize that pelvic splinting via external compression will improve patients' pain regardless of whether they have a pelvic, acetabular, or proximal femur fracture.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
- Traumatic injury other than ground-level fall, and
- Complaint of pelvic groin or hip pain, or
- Pelvic or hip deformity, ecchymosis, or crepitus in an obtunded patient, or
- Hemodynamic instability
- Ground level fall
- Penetrating pelvis injury without frank evidence of fracture
- Obviously pregnant patients
- Patients who are too small or too big for the binder
- Priority 2 or 3 Trauma
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Pelvic Binder Pelvic Binder Commercially available device used to stabilize the pelvis
- Primary Outcome Measures
Name Time Method Mortality Rate 30 day Percentage of patients that experience mortality within 30 days of presentation will be compared between the two study arms
- Secondary Outcome Measures
Name Time Method Pain Scores - Visual Analog Scale At time of arrival to Emergency Department Pain scores at presentation to hospital will be compared between the two study arms. Range 0-10. Higher scores indicate a worse outcome.
Number of Participants With Skin Complications After Pelvic Binder Application From date of randomization to date of discharge or date of death from any cause, whichever came first, assessed up to 1 year The rate of occurrence of skin complications after binder application will be documented.
Length of Stay in Hospital From date of admission to date of discharge or date of death from any cause, whichever came first, assessed up to 1 year The total number of days the patient spent in the hospital
Number of Patients With Blood Transfusions 48 hours Number of Blood Transfusions within the first 48 hours after hospital admission
Trial Locations
- Locations (1)
Carolinas Medical Center
🇺🇸Charlotte, North Carolina, United States